Aktis Oncology, Inc.
AKTS
$20.34
$1.226.38%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 137.44% | 0.00% | |||
| Total Receivables | 100.00% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 34.38% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 136.18% | -- | |||
|
|
|||||
| Total Current Assets | 136.18% | -- | |||
| Net Property, Plant & Equipment | 3.17% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -35.19% | -- | |||
| Total Assets | 117.76% | -- | |||
|
|
|||||
| Total Accounts Payable | -29.36% | -- | |||
| Total Accrued Expenses | -33.86% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 8.75% | -- | |||
| Total Finance Division Other Current Liabilities | 1.59% | -- | |||
| Total Other Current Liabilities | 1.59% | -- | |||
| Total Current Liabilities | -10.64% | -- | |||
|
|
|||||
| Total Current Liabilities | -10.64% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -0.84% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -9.74% | -- | |||
| Total Liabilities | -8.93% | -- | |||
|
|
|||||
| Common Stock & APIC | 6,467.42% | -- | |||
| Retained Earnings | -11.70% | -- | |||
| Treasury Stock & Other | -673.81% | -- | |||
| Total Common Equity | 446.30% | 0.00% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 0.00% | |||
|
|
|||||
| Total Common Equity | 446.30% | 0.00% | |||
| Total Preferred Equity | -- | 0.00% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 170.27% | 0.00% | |||
|
|
|||||